These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3500158)

  • 1. In vitro and in vivo evaluations of BMY-28100, a new oral cephalosporin.
    Tomatsu K; Ando S; Masuyoshi S; Kondo S; Hirano M; Miyaki T; Kawaguchi H
    J Antibiot (Tokyo); 1987 Aug; 40(8):1175-83. PubMed ID: 3500158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BMY-28100, a new oral cephalosporin: antimicrobial activity against nearly 7,000 recent clinical isolates, comparative potency with other oral agents, and activity against beta-lactamase producing isolates.
    Jones RN; Barry AL
    Diagn Microbiol Infect Dis; 1988 Jan; 9(1):11-26. PubMed ID: 3259489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BMY 28100, a new oral cephalosporin.
    Leitner F; Pursiano TA; Buck RE; Tsai YH; Chisholm DR; Misiek M; Desiderio JV; Kessler RE
    Antimicrob Agents Chemother; 1987 Feb; 31(2):238-43. PubMed ID: 3105449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity and beta-lactamase stability of the oral cephalosporin BMY-28100.
    Hiraoka M; Masuyoshi S; Tomatsu K; Inoue M; Mitsuhashi S
    Eur J Clin Microbiol; 1987 Oct; 6(5):559-63. PubMed ID: 3501756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of BMY-28100, a new oral cephalosporin.
    Eliopoulos GM; Reiszner E; Wennersten C; Moellering RC
    Antimicrob Agents Chemother; 1987 Apr; 31(4):653-6. PubMed ID: 3496846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo antibacterial properties of FK 027, a new orally active cephem antibiotic.
    Kamimura T; Kojo H; Matsumoto Y; Mine Y; Goto S; Kuwahara S
    Antimicrob Agents Chemother; 1984 Jan; 25(1):98-104. PubMed ID: 6561017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative antibacterial activity of a new oral cephalosporin, BMY-28100.
    Chin NX; Neu HC
    Antimicrob Agents Chemother; 1987 Mar; 31(3):480-3. PubMed ID: 3495236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro activity of cefaclor (author's transl)].
    Knothe H
    Infection; 1979; 7 Suppl 6():518-26. PubMed ID: 45087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo antibacterial activity of KT3777, a new orally active carbacephem.
    Sato K; Okachi R; Matsukuma I; Mochida K; Hirata T
    J Antibiot (Tokyo); 1989 Dec; 42(12):1844-53. PubMed ID: 2621166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of Ro 15-8074 and Ro 19-5247 in comparison to cefaclor and cefalexin.
    Simon C
    Infection; 1987; 15(2):122-4. PubMed ID: 3596808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of in vitro antibacterial activity of three oral cephalosporins: cefaclor, cephalexin, and cephradine.
    Silver MS; Counts GW; Zeleznik D; Turck M
    Antimicrob Agents Chemother; 1977 Nov; 12(5):591-6. PubMed ID: 921255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Summary of laboratory studies on the antibacterial activity of cefaclor.
    Preston DA
    Postgrad Med J; 1979; 55 Suppl 4():22-9. PubMed ID: 398479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of BMY-28100, a new oral cephalosporin.
    Norden CW; Niederriter K
    Chemotherapy; 1988; 34(1):27-9. PubMed ID: 3258231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of in vitro antibacterial activity of four oral cephems: cephalexin, cefaclor, cefatrizine and cefadroxil.
    Luh KT; Chao HP; Ho SW; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1984 Feb; 17(1):11-8. PubMed ID: 6378550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo evaluations of a new broad-spectrum oral cephalosporin, BMY-28232, and its prodrug esters.
    Tomatsu K; Masuyoshi S; Hirano M; Kawaguchi H; Oki T; Fung-Tomc J; Desiderio JV; Kessler RE
    Antimicrob Agents Chemother; 1989 Apr; 33(4):489-97. PubMed ID: 2786371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial activity of LY163892, an orally administered 1-carbacephem.
    Jones RN; Barry AL
    J Antimicrob Chemother; 1988 Sep; 22(3):315-20. PubMed ID: 3182429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of in vitro activity of cephalexin, cephradine, and cefaclor.
    Bill NJ; Washington JA
    Antimicrob Agents Chemother; 1977 Mar; 11(3):470-4. PubMed ID: 301005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of action of the new orally active cephalosporin FK027.
    Shigi Y; Matsumoto Y; Kaizu M; Fujishita Y; Kojo H
    J Antibiot (Tokyo); 1984 Jul; 37(7):790-6. PubMed ID: 6381449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial activity and beta-lactamase stability of BMY-28232, parent compound of an oral cephalosporin.
    Chin NX; Yu KW; Neu HC
    Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):841-6. PubMed ID: 2086221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro activity of cefaclor, cephalexin and ampicillin against 2458 clinical isolates of Haemophilus influenzae.
    Powell M; Williams JD
    J Antimicrob Chemother; 1988 Jan; 21(1):27-31. PubMed ID: 3258594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.